CoChat

Checkpoint inhibitor-associated drug reaction with eosinophilia and systemic symptom syndrome

Mirza, Sayeef, Hill, Ebone’, Ludlow, Steven P., Nanjappa, Sowmya · 2017 · Melanoma Research

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

Drug reaction with eosinophilia and systemic symptom syndrome is a potentially fatal drug reaction that must be recognized quickly. Ipilimumab and nivolumab are both important agents in the treatment of melanoma and continue to be studied in other malignancies. We believe the mainstay of therapy for immunotherapy-induced drug reaction with eosinophilia and systemic symptom syndrome is early recognition, discontinuation of the inciting agent, supportive care, and treatment with high dose corticosteroids with appropriate tapers that may reduce the length of internal organ injury in cases with liver or kidney involvement.

Overview

Integrity signals

Registry

Crossref · 10.1097/cmr.0000000000000326

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists are queued

They are fetched later and appear here then.

References 22 · Cited by 58

Metadata

Authors
Mirza, S., Hill, E., Ludlow, S. P., & Nanjappa, S.
Affiliations
  • Department of Internal Medicine, University of South Florida, Tampa, Florida, USA
  • Moffitt Cancer Center (US)
Corresponding author
Ludlow, Steven P.
Venue
Melanoma Research
Published
2017-06
Volume
27
Issue
3
Pages
271-273
ISSN
0960-8931 (ISSN-L)
OpenAlex
W2586640730
Cited by
58
References
22
Citations by year
2026: 2 · 2025: 6 · 2024: 8 · 2023: 7 · 2022: 5 · 2021: 11 · 2020: 7 · 2019: 7 · 2018: 4 · 2017: 1
FWCI
2.29
Type
journal article
Language
en
Open access
closed
Locations
  • Melanoma Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
Keywords
DRESS syndrome, immune checkpoint inhibitors, ipilimumab, nivolumab, melanoma, immunotherapy adverse events, corticosteroid therapy, drug discontinuation, liver injury, kidney injury
MeSH terms
Antineoplastic Agents, Immunological, Ipilimumab, Nivolumab, Adrenal Cortex Hormones, Antibodies, Monoclonal, Eosinophilia, Humans, Immunotherapy, Male, Melanoma, Middle Aged, Prognosis, Cell Cycle Checkpoints, Drug Hypersensitivity Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Checkpoint inhibitor-associated drug reaction with eosinophilia and systemic symptom syndrome. https://app.cochat.ai/papers/10.1097/cmr.0000000000000326
The paper
Mirza, S., Hill, E., Ludlow, S. P., & Nanjappa, S. (2017). Checkpoint inhibitor-associated drug reaction with eosinophilia and systemic symptom syndrome. Melanoma Research. https://doi.org/10.1097/cmr.0000000000000326

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.